» Authors » Nikhil Jiwrajka

Nikhil Jiwrajka

Explore the profile of Nikhil Jiwrajka including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 78
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiwrajka N, Tuluc F, Jaimes M, Murray J, Anguera M
bioRxiv . 2025 Jan; PMID: 39868326
This 30-color panel was developed to enable the enumeration and purification of distinct circulating immune cell subsets implicated in the pathogenesis of systemic autoimmune diseases including rheumatoid arthritis (RA), systemic...
2.
Jiwrajka N, Anguera M
J Exp Med . 2025 Jan; 222(3. PMID: 39820256
Systemic sclerosis (SSc) is a debilitating autoimmune disease that preferentially afflicts women. The molecular origins of this female bias are unclear. A new study of plasmacytoid dendritic cells from SSc...
3.
Forsyth K, Toothacre N, Jiwrajka N, Driscoll A, Shallberg L, Cunningham-Rundles C, et al.
Sci Immunol . 2024 Oct; 9(100):eado0398. PMID: 39365876
X chromosome inactivation (XCI) balances X-linked gene dosage between sexes. Unstimulated T cells lack cytological enrichment of X-inactive specific transcript (Xist) RNA and heterochromatic modifications on the inactive X chromosome...
4.
Johnson S, Bernstein E, Bolster M, Chung J, Danoff S, George M, et al.
Arthritis Rheumatol . 2024 Jul; 76(8):1182-1200. PMID: 38978310
Objective: We provide evidence-based recommendations regarding the treatment of interstitial lung disease (ILD) in adults with systemic autoimmune rheumatic diseases (SARDs). Methods: We developed clinically relevant population, intervention, comparator, and...
5.
Johnson S, Bernstein E, Bolster M, Chung J, Danoff S, George M, et al.
Arthritis Care Res (Hoboken) . 2024 Jul; 76(8):1051-1069. PMID: 38973731
Objective: We provide evidence-based recommendations regarding the treatment of interstitial lung disease (ILD) in adults with systemic autoimmune rheumatic diseases (SARDs). Methods: We developed clinically relevant population, intervention, comparator, and...
6.
Johnson S, Bernstein E, Bolster M, Chung J, Danoff S, George M, et al.
Arthritis Care Res (Hoboken) . 2024 Jul; 76(8):1070-1082. PMID: 38973729
Objective: We provide evidence-based recommendations regarding screening for interstitial lung disease (ILD) and the monitoring for ILD progression in people with systemic autoimmune rheumatic diseases (SARDs), specifically rheumatoid arthritis, systemic...
7.
Johnson S, Bernstein E, Bolster M, Chung J, Danoff S, George M, et al.
Arthritis Rheumatol . 2024 Jul; 76(8):1201-1213. PMID: 38973714
Objective: We provide evidence-based recommendations regarding screening for interstitial lung disease (ILD) and the monitoring for ILD progression in people with systemic autoimmune rheumatic diseases (SARDs), specifically rheumatoid arthritis, systemic...
8.
Lovell C, Jiwrajka N, Amerman H, Cancro M, Anguera M
bioRxiv . 2024 May; PMID: 38798403
Systemic lupus erythematosus (SLE) is an autoimmune disease preferentially observed in females. X-linked gene expression in XX females is normalized to that of XY males by X-Chromosome Inactivation (XCI). However,...
9.
Forsyth K, Toothacre N, Jiwrajka N, Driscoll A, Shallberg L, Cunningham-Rundles C, et al.
bioRxiv . 2024 Feb; PMID: 38405871
X Chromosome Inactivation (XCI) is a female-specific process which balances X-linked gene dosage between sexes. Unstimulated T cells lack cytological enrichment of RNA and heterochromatic modifications on the inactive X...
10.
Forsyth K, Jiwrajka N, Lovell C, Toothacre N, Anguera M
Nat Rev Immunol . 2024 Feb; 24(7):487-502. PMID: 38383754
There are notable sex-based differences in immune responses to pathogens and self-antigens, with female individuals exhibiting increased susceptibility to various autoimmune diseases, and male individuals displaying preferential susceptibility to some...